1.
|
Phase: Phase IV Type: Supportive care Status: Closed Age: 6 to 18 Sponsor: NCI, Other Protocol IDs: MEMFX2, RO1-CA078957, UO1-CA81445, P30-CA2Z1765, NCT00576472
|
|
2.
|
Phase: Phase III, Phase II Type: Supportive care Status: Completed Age: 18 to 60 Sponsor: Pharmaceutical / Industry Protocol IDs: 6520-9959-02, NCT00758407
|
|
3.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-2Z96, NCI-P98-0130, NCT00003266
|
|
4.
|
Phase: Phase III Type: Supportive care Status: Closed Age: 8 and over Sponsor: NCI Protocol IDs: NCCTG-899251, MAYO-899251, NCI-P90-0007
|
|
5.
|
Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N05C7, NCCTG N05C7, N05C7, NCT00376675
|
|
6.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: ID00-372, NCT00516269
|
|
7.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 6 to 17 Sponsor: NCI Protocol IDs: MCC-0201, NCI-5899, HLMCC 0201, NCT00069927
|
|
8.
|
Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: 02-100, NCT00138138
|
|
9.
|
Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: Other Protocol IDs: IIR 03-194, 01153, 10-0603, CPC-04115-LX, NCT00129467
|
|
10.
|
Phase: No phase specified Type: Educational/Counseling/Training, Supportive care Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: 2005-0613, NCT00424099
|